These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8488155)

  • 41. In vivo comparison of the follicle-stimulating hormone-suppressing activity of follistatin and inhibin in ovariectomized rats.
    DePaolo LV; Shimonaka M; Schwall RH; Ling N
    Endocrinology; 1991 Feb; 128(2):668-74. PubMed ID: 1899217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of gonadotrophin secretion by inhibin, testosterone and gonadotrophin-releasing hormone in pituitary cell cultures of male monkeys.
    Fingscheidt U; Weinbauer GF; Fehm HL; Nieschlag E
    J Endocrinol; 1998 Oct; 159(1):103-10. PubMed ID: 9795347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells.
    Ying SY; Becker A; Ling N; Ueno N; Guillemin R
    Biochem Biophys Res Commun; 1986 May; 136(3):969-75. PubMed ID: 3087350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion.
    Weiss J; Crowley WF; Halvorson LM; Jameson JL
    Endocrinology; 1993 Jun; 132(6):2307-11. PubMed ID: 8504735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibin B, follicle stimulating hormone, luteinizing hormone and testosterone during childhood and puberty in males: changes in serum concentrations in relation to age and stage of puberty.
    Chada M; Průsa R; Bronský J; Kotaska K; Sídlová K; Pechová M; Lisá L
    Physiol Res; 2003; 52(1):45-51. PubMed ID: 12625806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of inhibin in adult male rats: the effect of inhibin deficiency and androgen antagonism on serum and pituitary gonadotrophins.
    Lipner H; Dhanarajan P
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):302-7. PubMed ID: 6422685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
    Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of rat prostatic inhibinlike peptide (PIP) by steroids and protein hormones.
    Teni TR; Sheth AR; Sheth NA
    Arch Androl; 1988; 20(3):211-7. PubMed ID: 3190354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
    Zaccheo T; Giudici D; di Salle E
    Prostate; 1997 Feb; 30(2):85-91. PubMed ID: 9051146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential regulation of FSH and inhibin gene expression and synthesis by testosterone in immature and mature male rats.
    Perheentupa A; Bergendahl M; de Jong FH; Huhtaniemi I
    J Endocrinol; 1993 Apr; 137(1):69-79. PubMed ID: 8492078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RU486 blocks the effects of inhibin antiserum or luteinizing hormone on the secondary follicle-stimulating hormone surge.
    Knox KL; Ringstrom SJ; Schwartz NB
    Endocrinology; 1993 Jul; 133(1):277-83. PubMed ID: 8319576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seasonal changes in the negative feedback regulation of the secretion of the gonadotrophins by testosterone and inhibin in rams.
    Tilbrook AJ; de Kretser DM; Clarke IJ
    J Endocrinol; 1999 Jan; 160(1):155-67. PubMed ID: 9854187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.
    Jungwirth A; Galvan G; Pinski J; Halmos G; Szepeshazi K; Cai RZ; Groot K; Schally AV
    Prostate; 1997 Aug; 32(3):164-72. PubMed ID: 9254895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous 17 beta-estradiol in treatment of cancer of prostate.
    Steg A; Benoit G
    Urology; 1979 Oct; 14(4):373-5. PubMed ID: 227153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A synthetic decapeptide analogue of human seminal plasma inhibin exhibiting specific suppression of follicle stimulating hormone release in rats.
    Iyer KS; Mahale SD; Hurkadli KS; Sheth AR
    Indian J Exp Biol; 1989 Jan; 27(1):10-3. PubMed ID: 2514142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations in the ability of the bovine pituitary gland to secrete gonadotropins in vitro during the first follicle-stimulating hormone increase of the estrous cycle and in response to exogenous steroids.
    Lane EA; Padmanabhan V; Roche JF; Crowe MA
    Domest Anim Endocrinol; 2005 Feb; 28(2):190-201. PubMed ID: 15713366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.